Olivier bohuon pierre fabre dermo
To top. KG other. You are currently not logged in to my. OTE, 1. Auch interessant: Inhalt wird geladen Keep logged in. Read what you need to know about our industry portal bionity. It employs a workforce of nearly 10, including 1, in research.
CASTRES, France, July 2 /CNW/ - Olivier Bohuon will be replacing Jean-Pierre as Chief Executive Officer at Pierre Fabre Group starting September 1, company and leader in the field of in-pharmacy dermo-cosmetics.
CASTRES, France, July 2, /PRNewswire/ -- Olivier Bohuon will be replacing Garnier as Chief Executive Officer at Pierre Fabre Group starting company and leader in the field of in-pharmacy dermo-cosmetics. Olivier Bohuon Appointed Chief Executive Officer of Pierre Fabre SA - read nervous system, dermatology and cardio-vascular/metabolism.
About the Pierre Fabre group The Pierre Fabre group, owned on a majority basis by a public utility Foundation, is France's second largest independent pharmaceutics laboratory and the leader in cosmetics products sold in pharmacies.
Meistgelesen Personalia Bildung Unternehmen.
Bloomberg Are you a robot
Cookies deactivated. Your changes will in fact be stored however can be lost at all times. About bionity.
Olivier Bohuon Elected to LEO Pharma's Board of Directors Business Wire
Olivier Bohuon Pierre Fabre SA The Company provides dermatology and critical care products for the treatment of. Dermatology and pharmaceutical company Pierre Fabre will be headed up by Olivier Bohuon from September of this year.
Video: Olivier bohuon pierre fabre dermo FONDATION PIERRE FABRE - 20 ans d'action, un engagement sur le terrain
Olivier BOHUON has also been appointed president of Pierre Fabre central nervous system, dermatology and cardio-vascular/metabolism.
It employs a workforce of nearly 10, including 1, in research. Meistgelesen Personalia Bildung Unternehmen.
Olivier Bohuon becomes new CEO of Pierre Fabre
KG other. Partner Presseportal. Request information now Add company to watchlist Recommend company. Pierre Fabre and Roche extend collaboration agreement on companion diagnostic development.
Laboratoires Pierre Fabre SA Castres, France
Widerrufsrecht zeitschriften internet movie
Request information now. Investment in research has resulted in the discovery of new molecules, and this effort has enabled the firm to reinforce and emphasise its world-wide development.
Groupe Pierre Fabre Zum Pressroom. ScinoPharm wird in Tanvex Important information. Your browser is not current.